Who
Mark Fennell
Chief Legal Officer &Secretary
Company insider
Files Form 4 as: Chief Legal Officer &Secretary, Cognex.
In numbers
- Trades disclosed
- 52
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $8.7M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 16 Feb 2021
- Last trade
- 11 May 2026
- Last filed
- 12 May 2026
Companies traded
Activity over time
1 May – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 May 2026filed 12 May 2026 | CGNX CognexLife-science tools | SEC FORM 4 Code M | $330K6,400 at $51.49 | filing |
| 11 May 2026filed 12 May 2026 | CGNX CognexLife-science tools | SEC FORM 4 Sold | $644K9,600 at $67.08 | filing |
| 11 May 2026filed 12 May 2026 | CGNX CognexLife-science tools | SEC FORM 4 Code M | $171K4,000 at $42.84 | filing |
| 11 May 2026filed 12 May 2026 | CGNX CognexLife-science tools | SEC FORM 4 Sold | $268K4,000 at $67.08 | filing |
| 11 May 2026filed 12 May 2026 | CGNX CognexLife-science tools | SEC FORM 4 Sold | $325K4,863 at $66.73 | filing |
| 11 May 2026filed 12 May 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code M | —6,634 at $0.00 | filing |
| 11 May 2026filed 12 May 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code M | —15,080 at $0.00 | filing |
| 11 May 2026filed 12 May 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code M | —4,000 at $0.00 | filing |
| 11 May 2026filed 12 May 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code M | —18,296 at $0.00 | filing |
| 11 May 2026filed 12 May 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code M | —6,400 at $0.00 | filing |
| 11 May 2026filed 12 May 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code M | —9,600 at $0.00 | filing |
| 11 May 2026filed 12 May 2026 | CGNX CognexLife-science tools | SEC FORM 4 Sold | $429K6,400 at $67.08 | filing |
| 11 May 2026filed 12 May 2026 | CGNX CognexLife-science tools | SEC FORM 4 Code M | $864K18,296 at $47.21 | filing |
| 11 May 2026filed 12 May 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code M | —6,634 at $0.00 | filing |
| 11 May 2026filed 12 May 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code M | —15,080 at $0.00 | filing |
| 11 May 2026filed 12 May 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code M | —4,000 at $0.00 | filing |
| 11 May 2026filed 12 May 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code M | —18,296 at $0.00 | filing |
| 11 May 2026filed 12 May 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code M | —6,400 at $0.00 | filing |
| 11 May 2026filed 12 May 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code M | —9,600 at $0.00 | filing |
| 11 May 2026filed 12 May 2026 | CGNX CognexLife-science tools | SEC FORM 4 Sold | $1.2M18,296 at $67.08 | filing |
News
Barclays Forecasts Strong Price Appreciation for Cognex (NASDAQ:CGNX) StockCGNX · themarketsdaily.com · 12 Oct 2026Cognex (NASDAQ:CGNX) Stock Price Down 7.3% After Analyst DowngradeCGNX · themarketsdaily.com · 9 Oct 2026
0 headlines in the last 90 days name Mark Fennell; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.